title: Letter to the editor on 'Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial'.
authors.affiliation: Breast Unit, The Royal Marsden NHS Foundation Trust, London;; The Institute of Cancer Research, London, UK. Electronic address: peter.barry@icr.ac.uk.
authors.forename: P A
authors.initials: PA
authors.lastname: Barry
authors.affiliation: Breast Unit, The Royal Marsden NHS Foundation Trust, London;; The Institute of Cancer Research, London, UK.
authors.forename: G
authors.initials: G
authors.lastname: Schiavon
authors.affiliation: Breast Unit, The Royal Marsden NHS Foundation Trust, London.
authors.forename: F A
authors.initials: FA
authors.lastname: MacNeill
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D020360:Neoadjuvant Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism*
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases